Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingcai Li

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
International Immunopharmacology|May 24, 2011
The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseasesQing Lin, Mingcai Li, Dan Fang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 24, 2022
Increased serum IL-41 is associated with disease activity in rheumatoid arthritisLuping Gong, Yinxin Zhou, Shanjun Shi, et al.
Molecular and Cellular Biochemistry|September 28, 2023
Elevated serum IL-36γ levels in patients with ankylosing spondylitis and its association with disease activityShanjun Shi, Wubing Lu, Yinxin Zhou, et al.
Plos One|April 30, 2015
Climate impacts on extreme energy consumption of different types of buildingsMingcai Li, Jun Shi, Jun Guo, et al.
Biochemical and Biophysical Research Communications|June 11, 2009
Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthmaXiaojin Liu, Mingcai Li, Yan Wu, et al.
Immunopharmacology and Immunotoxicology|January 8, 2021
Interleukin-39 exacerbates concanavalin A-induced liver injuryYan Li, Luping Gong, Linjie Weng, et al.
Clinical Biochemistry|December 5, 2022
Clinical significance of elevated serum IL-36γ levels in patients with early-stage Hashimoto's thyroiditisShanjun Shi, Yinxin Zhou, Luping Gong, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 20, 2022
The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its ComplicationsGuoqing Huang, Mingcai Li, Xiaoqing Tian, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 14, 2022
Protective Effects of Interleukin-37 Expression against Acetaminophen-Induced Hepatotoxicity in MiceZhiwei Xu, Kan Li, Xiuhe Pan, et al.
Frontiers in Immunology|November 1, 2024
The decreased serum levels of interleukin-38 in patients with gout and its clinical significanceHua Huang, Yinxin Zhou, Yan Li, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
International Immunopharmacology|May 24, 2011
The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseasesQing Lin, Mingcai Li, Dan Fang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 24, 2022
Increased serum IL-41 is associated with disease activity in rheumatoid arthritisLuping Gong, Yinxin Zhou, Shanjun Shi, et al.
Molecular and Cellular Biochemistry|September 28, 2023
Elevated serum IL-36γ levels in patients with ankylosing spondylitis and its association with disease activityShanjun Shi, Wubing Lu, Yinxin Zhou, et al.
Plos One|April 30, 2015
Climate impacts on extreme energy consumption of different types of buildingsMingcai Li, Jun Shi, Jun Guo, et al.
Biochemical and Biophysical Research Communications|June 11, 2009
Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthmaXiaojin Liu, Mingcai Li, Yan Wu, et al.
Immunopharmacology and Immunotoxicology|January 8, 2021
Interleukin-39 exacerbates concanavalin A-induced liver injuryYan Li, Luping Gong, Linjie Weng, et al.
Clinical Biochemistry|December 5, 2022
Clinical significance of elevated serum IL-36γ levels in patients with early-stage Hashimoto's thyroiditisShanjun Shi, Yinxin Zhou, Luping Gong, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 20, 2022
The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its ComplicationsGuoqing Huang, Mingcai Li, Xiaoqing Tian, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 14, 2022
Protective Effects of Interleukin-37 Expression against Acetaminophen-Induced Hepatotoxicity in MiceZhiwei Xu, Kan Li, Xiuhe Pan, et al.
Frontiers in Immunology|November 1, 2024
The decreased serum levels of interleukin-38 in patients with gout and its clinical significanceHua Huang, Yinxin Zhou, Yan Li, et al.
Pageof 7